Menorrhagia is defined as a complaint of heavy cyclical
menstrual bleeding over several consecutive cycles. It is a common
problem and accounts for 35% of consultations in gynaecology outpatient
departments. Hysterectomy, traditionally the definitive treatment for
menorrhagia in approximately 60% of cases, is a major operation with
potential morbidity and mortality.
Alternatives include medical treatment, which can be limited by the unfavourable side effects and lack of efficacy. The progestogen-releasing IUS is an effective and well-tolerated alternative and is being increasingly used; however, it is not suitable if the uterine cavity is distorted by fibroids.
Surgical options of management also include minimal invasive procedures such as first generation endometrial resection/ablation and second generation endometrial ablative techniques which are continuously evolving with improved safety and efficacy. The aim of the treatment is to limit uterine bleeding or produce amenorrhoea that is a type of therapeutic Asherman’s syndrome.